[Federal Register Volume 62, Number 166 (Wednesday, August 27, 1997)]
[Notices]
[Page 45424]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-22705]
[[Page 45424]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Advisory Committee; Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). At least one
portion of the meeting will be closed to the public.
Name of Committee: Biological Response Modifiers Advisory
Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA regulatory issues.
Date and Time: The meeting will be held on September 17, 1997, 5
p.m. to 7 p.m. by teleconference.
Location: Food and Drug Administration, Bldg. 29, conference room
121, 8800 Rockville Pike, Rockville, MD. This meeting will be held by a
telephone conference call. A speaker telephone will be provided in the
conference room to allow public participation in the meeting.
Contact Person: Gail M. Dapolito or Rosanna L. Harvey, Center for
Biologics Evaluation and Research (HFM-21), Food and Drug
Administration, 1401 Rockville Pike, Rockville, MD 20852, 301-827-0314,
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area), code 12388. Please call the
Information Line for up-to-date information on this meeting.
Agenda: The committee will discuss the intramural scientific
programs of the Laboratory of Molecular and Developmental Immunology
and an individual in the Molecular Immunology Laboratory.
Procedure: On September 17, 1997, from 5 p.m. to 6 p.m., the
meeting is open to the public. Interested persons may present data,
information, or views, orally or in writing, on issues pending before
the committee. Written submissions may be made to the contact person by
September 10, 1997. Oral presentations from the public will be
scheduled between approximately 5 p.m. and 6 p.m. Time allotted for
each presentation may be limited. Those desiring to make formal oral
presentations should notify the contact person before September 10,
1997, and submit a brief statement of the general nature of the
evidence or arguments they wish to present, the names and addresses of
proposed participants, and an indication of the approximate time
requested to make their presentation.
Closed committee deliberations: On September 17, 1997, from 6 p.m.
to 7 p.m., the meeting will be closed to permit discussion where
disclosure would constitute a clearly unwarranted invasion of personal
privacy (5 U.S.C. 552b(c)(6)). The meeting will be closed to discuss
personal information concerning individuals associated with the
research programs.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: August 19, 1997.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 97-22705 Filed 8-26-97; 8:45 am]
BILLING CODE 4160-01-F
